{"latest_checked": "2026-10-14T12:30:18.613659+00:00", "coverage_count": 5027, "intelligence": {"score": 28, "label": "Broad disposal tilt", "tone": "negative", "stance": "Check participation, transaction context and price together", "brief": "Priced common-share disposals outweigh acquisitions across the participating insiders. Each qualifying company has equal weight in this group reading.", "confidence": 12, "confidence_label": "Purpose not verified", "filings": 2, "companies": 1, "qualified_companies": 1, "insiders": 1, "signal_events": 1, "acquisition_events": 0, "disposal_events": 1, "acquisition_share": 0.0, "disposal_share": 100.0, "acquisition_value": 0.0, "disposal_value": 914400.0, "net_value": -914400.0, "acquisition_value_label": "$0", "disposal_value_label": "$914.4K", "net_value_label": "-$914.4K", "data_quality": 100, "priced_common_share": 50, "latest_date": "2026-08-04", "latest_signal_date": "2026-08-04", "oldest_date": "2026-08-04", "recent_acquirers": 0, "cluster_companies": 0, "repeat_acquirers": 0, "largest_person_share": 100, "acquisition_companies": 0, "disposal_companies": 1, "method_version": "insider-2.0", "purpose_verified": false, "evidence_classes": [{"key": "common_equity", "label": "Common equity", "count": 2, "bar_width": 100.0}, {"key": "equity_award", "label": "Equity compensation", "count": 0, "bar_width": 0.0}, {"key": "derivative", "label": "Options and derivatives", "count": 0, "bar_width": 0.0}, {"key": "other", "label": "Other securities", "count": 0, "bar_width": 0.0}], "roles": [{"label": "Other executive", "count": 2, "bar_width": 100.0}], "supports": ["1 priced common-share events after duplicate controls.", "1 named participants across 1 companies."], "risks": ["Transaction codes, filing dates and trading-plan flags are not supplied. Acquisitions are not verified discretionary purchases.", "The latest usable transaction is more than two weeks old."]}, "freshness": {"total": 5027, "checked": 4982, "errors": 45, "latest": "2026-10-14T12:30:18.613Z", "session": "2026-10-14", "share": 99.1, "pending": 45}, "participation": [{"date": "2026-07-27", "acquirers": 0, "disposers": 0}, {"date": "2026-08-03", "acquirers": 0, "disposers": 1}, {"date": "2026-08-10", "acquirers": 0, "disposers": 0}, {"date": "2026-08-17", "acquirers": 0, "disposers": 0}, {"date": "2026-08-24", "acquirers": 0, "disposers": 0}, {"date": "2026-08-31", "acquirers": 0, "disposers": 0}, {"date": "2026-09-07", "acquirers": 0, "disposers": 0}, {"date": "2026-09-14", "acquirers": 0, "disposers": 0}, {"date": "2026-09-21", "acquirers": 0, "disposers": 0}, {"date": "2026-09-28", "acquirers": 0, "disposers": 0}, {"date": "2026-10-05", "acquirers": 0, "disposers": 0}, {"date": "2026-10-12", "acquirers": 0, "disposers": 0}], "recent_count": 2, "transaction_limit": 160, "filters": {"q": "", "ticker": "AGIO", "sector": "", "industry": "", "side": "", "start": "2026-07-17", "end": "2026-10-14"}, "summary": {"total": 2, "acquisition_count": 0, "disposal_count": 1, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 914400.0, "disposal_value_label": "$914.4K", "net_value": -914400.0, "net_value_label": "$-914.4K", "flow_tone": "negative", "largest_value_label": "$914.4K", "top_sector": "Healthcare", "window_label": "17 Jul 2026 to 14 Oct 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 2, "value": "1828800.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$1.8M"}], "days": [{"transaction_date": "2026-08-04", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 100.0}], "side_mix": {"acquisitions": 0, "disposals": 1, "acquisition_share": 0.0, "disposal_share": 100.0}}, "company_flows": [{"symbol": "AGIO", "name": "Agios Pharm", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-08-04", "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 914400.0, "disposed_value_label": "$914.4K", "net_value": -914400.0, "net_value_label": "$-914.4K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}], "company_overview": [{"symbol": "AGIO", "name": "Agios Pharm", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-08-04", "filings": 2, "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 914400.0, "disposed_value_label": "$914.4K", "net_value": -914400.0, "net_value_label": "$-914.4K", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}], "transactions": [{"symbol": "AGIO", "name": "Agios Pharm", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "GHEUENS, SARAH", "executive_title": "Chief Medical Officer", "security_type": "Common stock", "side_code": "D", "side": "Disposal", "shares": 30000.0, "share_price": 30.48, "transaction_value": 914400.0, "transaction_value_label": "$914.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T10:04:22.470397+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}, {"symbol": "AGIO", "name": "Agios Pharm", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "GHEUENS, SARAH", "executive_title": "Chief Medical Officer", "security_type": "Common stock", "side_code": "S", "side": "S", "shares": 30000.0, "share_price": 30.48, "transaction_value": 914400.0, "transaction_value_label": "$914.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-14T09:57:05.602568+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}